News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

Prosensa (RNA) Intercept (ICPT) Elan (ELN) Herceptin Ridaforolimus Endometrial Cancer REGULUS (RGLS) Genentech galapagos (GLPG) Cytokinetics (CYTK) Agenus (AGEN ARGOS (ARGS) Mirati Therapeutics (MRTX) CRISPR Therapeutics (CRSP) Micromet (MITI) Theravance Bio Pharma (TBPH) Sequenom (SQNM) Merck (MRK) OncoCyte (OCX) AERIE PHARMACEUTICALS Dendreon (DNDN) Theravance (THRX) Revlimid (lenolidamide) Roche (ROCHE) Exelixis (EXEL) OSI (OSIP) Gilead (GILD) TOKAI (TKAOI) Alder Biopharmaceuticals (ALDR) Anacor (ANAC) Idenix (IDIX) Sangamo (SGMO) HALOZYME (HALO) Biogen Idec (BIIB) Jazz Pharmaceuticals (JAZZ) Adaptimmune (ADAP) Editas (EDIT) Regeneron (REGN) Rapamune Onyx (ONXX) JUNO (JUNO) Sanofi (SNY) Biocryst (BCRX) C4 Therapeutics ZALTRAP™ Zerenex AGOS (ARGS) Alnylam (ALNY) MODERNA ISIS (ISIS) Seattle Genetics (SGEN) NOVOCURE (NVCR) NANTKWEST (NK) Bristol-Myers Squibb (BMY) Telaprevir Advaxis (ADXS) Array Pharmaceuticals (ARRY) CompuGen (CGEN) Human Longevity (HLI) JOUNCE THERAPEUTICS (JNCE) Human Genome Sciences (HGSI) ACADIA (ACAD) BIOMARIN (BMRN) PTC Therapeutics (PTCT) GlaxoSmithKline (GSK) Vertex (VRTX) Ionis (IONS) Agenus (AGEN) Intermune (ITMN) ARCA (ABIO) Benlysta (belimumab) Bellicum (BLCM) Tysabri Abbott Laboratories (ABT) VANDA (VNDA) AstraZeneca (AZN) SUNESIS PHARMACEUTICALS (SNSS) ImmunoGen (IMGN) RenenxBio (RGNX) Ariad (ARIA) ABBVIE (ABBV) Multiple Myeloma Intrexon (XON) Galena (GALE) Amgen (AMGN) Ocular Therapeutix (OCUL) Prolor Biotech (PBTH) PORTOLA (PTLA) Aimmune Therapeutics (AIMT) Velcade (bortezomib) Vitae Pharmaceuticals (VTAE) KERYX (KERX) Pluristem (PSTI) Sanofi (SNA) SERES THERAPEUTICS (MCRB) Xoma (XOMA) Valeant Pharmaceuticals International (VRX) Global Cell Therapeutics (GBT) Ziofpharm (ZIOP) GUARDIAN HEALTH SYNTA (SNTA) LEXICON (LXRX) Auspex (ASPX) Sanofi-Aventis (SAN) INNOVIVA (INVA) Spike Therapeutics (ONCE) IDERA (IDRA) Sarepta (SRPT) ADVENTRIX (ANX) KITE (KITE) Roche (RHHBY) Incyte (INCY) Inovio (INO) Illumina (ILMN) CEMPRA (CEMP) Trastuzumab-DM1 NEKTAR (NKTR)) Dynavax (DVAX) Anadys (ANDS)